Bob 1 Rabbit Polyclonal Antibody
Bob 1 Rabbit Polyclonal Antibody
 Bob 1 Polyclonal Antibody |
|||
| ABP57915-02ml | Abbkine | 0.2ml | 496.8 EUR |
|
Description: A polyclonal antibody for detection of Bob 1 from Human. This Bob 1 antibody is for IHC-P, ELISA. It is affinity-purified from rabbit serum by affinity-chromatography using the specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from part region of human Bob 1 protein at amino acid sequence of 201-250 |
|||
Bob 1 Polyclonal Antibody |
|||
| ES8740-100ul | ELK Biotech | 100ul | 334.8 EUR |
|
Description: A Rabbit Polyclonal antibody against Bob 1 from Human. This antibody is tested and validated for IHC, WB, ELISA |
|||
Bob 1 Polyclonal Antibody |
|||
| ES8740-50ul | ELK Biotech | 50ul | 248.4 EUR |
|
Description: A Rabbit Polyclonal antibody against Bob 1 from Human. This antibody is tested and validated for IHC, WB, ELISA |
|||
Bob 1 Polyclonal Antibody |
|||
| 46860-100ul | SAB | 100ul | 302.4 EUR |
Bob 1 Polyclonal Antibody |
|||
| 46860-50ul | SAB | 50ul | 224.4 EUR |
 Bob 1 Polyclonal Conjugated Antibody |
|||
| C46860 | SAB | 100ul | 476.4 EUR |
 BOB-1 Antibody |
|||
| R30579 | NSJ Bioreagents | 100 ug | 419 EUR |
 Anti-BOB.1 antibody |
|||
| STJ180019 | St John's Laboratory | 0.1 ml | 306 EUR |
 Anti-Bob 1 antibody |
|||
| STJ98803 | St John's Laboratory | 200 µl | 236.4 EUR |
|
Description: Rabbit polyclonal to Bob 1. |
|||
 POU2AF1 Antibody / BOB-1 |
|||
| F55017-0.08ML | NSJ Bioreagents | 0.08 ml | 165 EUR |
POU2AF1 Antibody / BOB-1 |
|||
| F55017-0.4ML | NSJ Bioreagents | 0.4 ml | 379 EUR |
POU2AF1 Antibody / BOB-1 |
|||
| V8023-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
|
Description: BOB.1 expression in a variety of established B-cell lines, representing different stages of B-cell development, has suggested a constitutive, B-cell-specific expression pattern. LP cells in nodular lymphocyte predominant Hodgkin lymphoma, because they are germinal center-derived, are consistently immuno-positive for BOB.1. Conversely, only some cases of classical Hodgkin lymphoma show BOB.1 immuno-reactivity within the Hodgkin and Reed-Sternberg cells. Expression of BOB.1 has been reported in follicular center cell lymphoma, diffuse large B-cell lymphoma and some cases of acute myeloid leukemia. B-CLL, marginal zone lymphoma, and mantle cell lymphoma may show weak to moderate immunoreactivity. |
|||
POU2AF1 Antibody / BOB-1 |
|||
| V8023-20UG | NSJ Bioreagents | 20 ug | 219 EUR |
|
Description: BOB.1 expression in a variety of established B-cell lines, representing different stages of B-cell development, has suggested a constitutive, B-cell-specific expression pattern. LP cells in nodular lymphocyte predominant Hodgkin lymphoma, because they are germinal center-derived, are consistently immuno-positive for BOB.1. Conversely, only some cases of classical Hodgkin lymphoma show BOB.1 immuno-reactivity within the Hodgkin and Reed-Sternberg cells. Expression of BOB.1 has been reported in follicular center cell lymphoma, diffuse large B-cell lymphoma and some cases of acute myeloid leukemia. B-CLL, marginal zone lymphoma, and mantle cell lymphoma may show weak to moderate immunoreactivity. |
|||
POU2AF1 Antibody / BOB-1 |
|||
| V8023SAF-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
|
Description: BOB.1 expression in a variety of established B-cell lines, representing different stages of B-cell development, has suggested a constitutive, B-cell-specific expression pattern. LP cells in nodular lymphocyte predominant Hodgkin lymphoma, because they are germinal center-derived, are consistently immuno-positive for BOB.1. Conversely, only some cases of classical Hodgkin lymphoma show BOB.1 immuno-reactivity within the Hodgkin and Reed-Sternberg cells. Expression of BOB.1 has been reported in follicular center cell lymphoma, diffuse large B-cell lymphoma and some cases of acute myeloid leukemia. B-CLL, marginal zone lymphoma, and mantle cell lymphoma may show weak to moderate immunoreactivity. |
|||
POU2AF1 Antibody / BOB-1 |
|||
| V3902-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
|
Description: BOB-1, also called POU2AF1, expression in a variety of established B-cell lines, representing different stages of B-cell development, has suggested a constitutive, B-cell-specific expression pattern. LP cells in nodular lymphocyte predominant Hodgkin lymphoma, because they are germinal center-derived, are consistently immuno-positive for BOB-1. Conversely, only some cases of classical Hodgkin lymphoma show BOB-1 immuno-reactivity within the Hodgkin and Reed-Sternberg cells. Expression of BOB-1 has been reported in follicular center cell lymphoma, diffuse large B-cell lymphoma and some cases of acute myeloid leukemia. B-CLL, marginal zone lymphoma, and mantle cell lymphoma may show weak to moderate immunoreactivity. |
|||
POU2AF1 Antibody / BOB-1 |
|||
| V3902-20UG | NSJ Bioreagents | 20 ug | 219 EUR |
|
Description: BOB-1, also called POU2AF1, expression in a variety of established B-cell lines, representing different stages of B-cell development, has suggested a constitutive, B-cell-specific expression pattern. LP cells in nodular lymphocyte predominant Hodgkin lymphoma, because they are germinal center-derived, are consistently immuno-positive for BOB-1. Conversely, only some cases of classical Hodgkin lymphoma show BOB-1 immuno-reactivity within the Hodgkin and Reed-Sternberg cells. Expression of BOB-1 has been reported in follicular center cell lymphoma, diffuse large B-cell lymphoma and some cases of acute myeloid leukemia. B-CLL, marginal zone lymphoma, and mantle cell lymphoma may show weak to moderate immunoreactivity. |
|||
POU2AF1 Antibody / BOB-1 |
|||
| V3902SAF-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
|
Description: BOB-1, also called POU2AF1, expression in a variety of established B-cell lines, representing different stages of B-cell development, has suggested a constitutive, B-cell-specific expression pattern. LP cells in nodular lymphocyte predominant Hodgkin lymphoma, because they are germinal center-derived, are consistently immuno-positive for BOB-1. Conversely, only some cases of classical Hodgkin lymphoma show BOB-1 immuno-reactivity within the Hodgkin and Reed-Sternberg cells. Expression of BOB-1 has been reported in follicular center cell lymphoma, diffuse large B-cell lymphoma and some cases of acute myeloid leukemia. B-CLL, marginal zone lymphoma, and mantle cell lymphoma may show weak to moderate immunoreactivity. |
|||
POU2AF1 Antibody / BOB-1 |
|||
| V3903-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
|
Description: BOB1, also called POU2AF1, expression in a variety of established B-cell lines, representing different stages of B-cell development, has suggested a constitutive, B-cell-specific expression pattern. LP cells in nodular lymphocyte predominant Hodgkin lymphoma, because they are germinal center-derived, are consistently immuno-positive for BOB1. Conversely, only some cases of classical Hodgkin lymphoma show BOB1 immuno-reactivity within the Hodgkin and Reed-Sternberg cells. Expression of BOB1 has been reported in follicular center cell lymphoma, diffuse large B-cell lymphoma and some cases of acute myeloid leukemia. B-CLL, marginal zone lymphoma, and mantle cell lymphoma may show weak to moderate immunoreactivity. |
|||
POU2AF1 Antibody / BOB-1 |
|||
| V3903-20UG | NSJ Bioreagents | 20 ug | 219 EUR |
|
Description: BOB1, also called POU2AF1, expression in a variety of established B-cell lines, representing different stages of B-cell development, has suggested a constitutive, B-cell-specific expression pattern. LP cells in nodular lymphocyte predominant Hodgkin lymphoma, because they are germinal center-derived, are consistently immuno-positive for BOB1. Conversely, only some cases of classical Hodgkin lymphoma show BOB1 immuno-reactivity within the Hodgkin and Reed-Sternberg cells. Expression of BOB1 has been reported in follicular center cell lymphoma, diffuse large B-cell lymphoma and some cases of acute myeloid leukemia. B-CLL, marginal zone lymphoma, and mantle cell lymphoma may show weak to moderate immunoreactivity. |
|||
POU2AF1 Antibody / BOB-1 |
|||
| V3903SAF-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
|
Description: BOB1, also called POU2AF1, expression in a variety of established B-cell lines, representing different stages of B-cell development, has suggested a constitutive, B-cell-specific expression pattern. LP cells in nodular lymphocyte predominant Hodgkin lymphoma, because they are germinal center-derived, are consistently immuno-positive for BOB1. Conversely, only some cases of classical Hodgkin lymphoma show BOB1 immuno-reactivity within the Hodgkin and Reed-Sternberg cells. Expression of BOB1 has been reported in follicular center cell lymphoma, diffuse large B-cell lymphoma and some cases of acute myeloid leukemia. B-CLL, marginal zone lymphoma, and mantle cell lymphoma may show weak to moderate immunoreactivity. |
|||
POU2AF1 Antibody / BOB-1 |
|||
| V3915-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
|
Description: Transcriptional coactivator that specifically associates with either OCT1 or OCT2. It boosts the OCT1 mediated promoter activity and to a lesser extent, that of OCT2. It has no intrinsic DNA-binding activity. It recognizes the POU domains of OCT1 and OCT2. It is essential for the response of B-cells to antigens and required for the formation of germinal centers. [UniProt] |
|||
POU2AF1 Antibody / BOB-1 |
|||
| V3915-20UG | NSJ Bioreagents | 20 ug | 219 EUR |
|
Description: Transcriptional coactivator that specifically associates with either OCT1 or OCT2. It boosts the OCT1 mediated promoter activity and to a lesser extent, that of OCT2. It has no intrinsic DNA-binding activity. It recognizes the POU domains of OCT1 and OCT2. It is essential for the response of B-cells to antigens and required for the formation of germinal centers. [UniProt] |
|||
POU2AF1 Antibody / BOB-1 |
|||
| V3915SAF-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
|
Description: Transcriptional coactivator that specifically associates with either OCT1 or OCT2. It boosts the OCT1 mediated promoter activity and to a lesser extent, that of OCT2. It has no intrinsic DNA-binding activity. It recognizes the POU domains of OCT1 and OCT2. It is essential for the response of B-cells to antigens and required for the formation of germinal centers. [UniProt] |
|||
POU2AF1 Antibody / BOB-1 |
|||
| V3918-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
|
Description: BOB1, also called POU2AF1, expression in a variety of established B-cell lines, representing different stages of B-cell development, has suggested a constitutive, B-cell-specific expression pattern. LP cells in nodular lymphocyte predominant Hodgkin lymphoma, because they are germinal center-derived, are consistently immuno-positive for BOB1. Conversely, only some cases of classical Hodgkin lymphoma show BOB1 immuno-reactivity within the Hodgkin and Reed-Sternberg cells. Expression of BOB1 has been reported in follicular center cell lymphoma, diffuse large B-cell lymphoma and some cases of acute myeloid leukemia. B-CLL, marginal zone lymphoma, and mantle cell lymphoma may show weak to moderate immunoreactivity. |
|||
POU2AF1 Antibody / BOB-1 |
|||
| V3918-20UG | NSJ Bioreagents | 20 ug | 219 EUR |
|
Description: BOB1, also called POU2AF1, expression in a variety of established B-cell lines, representing different stages of B-cell development, has suggested a constitutive, B-cell-specific expression pattern. LP cells in nodular lymphocyte predominant Hodgkin lymphoma, because they are germinal center-derived, are consistently immuno-positive for BOB1. Conversely, only some cases of classical Hodgkin lymphoma show BOB1 immuno-reactivity within the Hodgkin and Reed-Sternberg cells. Expression of BOB1 has been reported in follicular center cell lymphoma, diffuse large B-cell lymphoma and some cases of acute myeloid leukemia. B-CLL, marginal zone lymphoma, and mantle cell lymphoma may show weak to moderate immunoreactivity. |
|||
POU2AF1 Antibody / BOB-1 |
|||
| V3918SAF-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
|
Description: BOB1, also called POU2AF1, expression in a variety of established B-cell lines, representing different stages of B-cell development, has suggested a constitutive, B-cell-specific expression pattern. LP cells in nodular lymphocyte predominant Hodgkin lymphoma, because they are germinal center-derived, are consistently immuno-positive for BOB1. Conversely, only some cases of classical Hodgkin lymphoma show BOB1 immuno-reactivity within the Hodgkin and Reed-Sternberg cells. Expression of BOB1 has been reported in follicular center cell lymphoma, diffuse large B-cell lymphoma and some cases of acute myeloid leukemia. B-CLL, marginal zone lymphoma, and mantle cell lymphoma may show weak to moderate immunoreactivity. |
|||
POU2AF1 Antibody / BOB-1 |
|||
| V7324-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
|
Description: BOB1, also called POU2AF1, expression in a variety of established B-cell lines, representing different stages of B-cell development, has suggested a constitutive, B-cell-specific expression pattern. LP cells in nodular lymphocyte predominant Hodgkin lymphoma, because they are germinal center-derived, are consistently immuno-positive for BOB1. Conversely, only some cases of classical Hodgkin lymphoma show BOB1 immuno-reactivity within the Hodgkin and Reed-Sternberg cells. Expression of BOB1 has been reported in follicular center cell lymphoma, diffuse large B-cell lymphoma and some cases of acute myeloid leukemia. B-CLL, marginal zone lymphoma, and mantle cell lymphoma may show weak to moderate immunoreactivity. |
|||
POU2AF1 Antibody / BOB-1 |
|||
| V7324-20UG | NSJ Bioreagents | 20 ug | 219 EUR |
|
Description: BOB1, also called POU2AF1, expression in a variety of established B-cell lines, representing different stages of B-cell development, has suggested a constitutive, B-cell-specific expression pattern. LP cells in nodular lymphocyte predominant Hodgkin lymphoma, because they are germinal center-derived, are consistently immuno-positive for BOB1. Conversely, only some cases of classical Hodgkin lymphoma show BOB1 immuno-reactivity within the Hodgkin and Reed-Sternberg cells. Expression of BOB1 has been reported in follicular center cell lymphoma, diffuse large B-cell lymphoma and some cases of acute myeloid leukemia. B-CLL, marginal zone lymphoma, and mantle cell lymphoma may show weak to moderate immunoreactivity. |
|||
POU2AF1 Antibody / BOB-1 |
|||
| V7324IHC-7ML | NSJ Bioreagents | 7 ml | 499 EUR |
|
Description: BOB1, also called POU2AF1, expression in a variety of established B-cell lines, representing different stages of B-cell development, has suggested a constitutive, B-cell-specific expression pattern. LP cells in nodular lymphocyte predominant Hodgkin lymphoma, because they are germinal center-derived, are consistently immuno-positive for BOB1. Conversely, only some cases of classical Hodgkin lymphoma show BOB1 immuno-reactivity within the Hodgkin and Reed-Sternberg cells. Expression of BOB1 has been reported in follicular center cell lymphoma, diffuse large B-cell lymphoma and some cases of acute myeloid leukemia. B-CLL, marginal zone lymphoma, and mantle cell lymphoma may show weak to moderate immunoreactivity. |
|||
POU2AF1 Antibody / BOB-1 |
|||
| V7324SAF-100UG | NSJ Bioreagents | 100 ug | 499 EUR |
|
Description: BOB1, also called POU2AF1, expression in a variety of established B-cell lines, representing different stages of B-cell development, has suggested a constitutive, B-cell-specific expression pattern. LP cells in nodular lymphocyte predominant Hodgkin lymphoma, because they are germinal center-derived, are consistently immuno-positive for BOB1. Conversely, only some cases of classical Hodgkin lymphoma show BOB1 immuno-reactivity within the Hodgkin and Reed-Sternberg cells. Expression of BOB1 has been reported in follicular center cell lymphoma, diffuse large B-cell lymphoma and some cases of acute myeloid leukemia. B-CLL, marginal zone lymphoma, and mantle cell lymphoma may show weak to moderate immunoreactivity. |
|||
 HRP-Goat Anti-Rabbit Secondary Antibody |
|||
| A12004 | EpiGentek |
|
|
 Goat Anti-Rabbit Secondary Antibody, Biotin Conjugated |
|||
| A12001 | EpiGentek |
|
|
) Polyclonal BOB / GPR15 Antibody (Cytoplasmic Domain) |
|||
| AMM05631G | Leading Biology | 0.05mg | 580.8 EUR |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human BOB / GPR15 (Cytoplasmic Domain). This antibody is tested and proven to work in the following applications: |
|||
) Polyclonal BOB / GPR15 Antibody (Extracellular Domain) |
|||
| AMM05632G | Leading Biology | 0.05mg | 580.8 EUR |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human BOB / GPR15 (Extracellular Domain). This antibody is tested and proven to work in the following applications: |
|||
 BOB.1 MonoSpecific Antibody, Unconjugated-20ug |
|||
| 5450-MSM4-P0 | EnQuireBio | 20ug | 279.6 EUR |
 BOB.1 MonoSpecific Antibody, Unconjugated-100ug |
|||
| 5450-MSM4-P1 | EnQuireBio | 100ug | 513.6 EUR |
 (BOB1/2423) Antibody) BOB.1 (B-Cell Marker) (BOB1/2423) Antibody |
|||
| BNC942423-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2423), CF594 conjugate, Concentration: 0.1mg/mL |
|||
BOB.1 (B-Cell Marker) (BOB1/2423) Antibody |
|||
| BNC942423-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2423), CF594 conjugate, Concentration: 0.1mg/mL |
|||
 (BOB1/2424) Antibody) BOB.1 (B-Cell Marker) (BOB1/2424) Antibody |
|||
| BNC942424-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2424), CF594 conjugate, Concentration: 0.1mg/mL |
|||
BOB.1 (B-Cell Marker) (BOB1/2424) Antibody |
|||
| BNC942424-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2424), CF594 conjugate, Concentration: 0.1mg/mL |
|||
 (BOB1/2425) Antibody) BOB.1 (B-Cell Marker) (BOB1/2425) Antibody |
|||
| BNC942425-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2425), CF594 conjugate, Concentration: 0.1mg/mL |
|||
BOB.1 (B-Cell Marker) (BOB1/2425) Antibody |
|||
| BNC942425-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2425), CF594 conjugate, Concentration: 0.1mg/mL |
|||
BOB.1 (B-Cell Marker) (BOB1/2423) Antibody |
|||
| BNCA2423-250 | Biotium | 250uL | 472.8 EUR |
|
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2423), APC conjugate, Concentration: 0.1mg/mL |
|||
BOB.1 (B-Cell Marker) (BOB1/2424) Antibody |
|||
| BNCA2424-250 | Biotium | 250uL | 472.8 EUR |
|
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2424), APC conjugate, Concentration: 0.1mg/mL |
|||
BOB.1 (B-Cell Marker) (BOB1/2425) Antibody |
|||
| BNCA2425-250 | Biotium | 250uL | 472.8 EUR |
|
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2425), APC conjugate, Concentration: 0.1mg/mL |
|||
BOB.1 (B-Cell Marker) (BOB1/2423) Antibody |
|||
| BNC552423-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2423), CF555 conjugate, Concentration: 0.1mg/mL |
|||
BOB.1 (B-Cell Marker) (BOB1/2423) Antibody |
|||
| BNC552423-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2423), CF555 conjugate, Concentration: 0.1mg/mL |
|||
BOB.1 (B-Cell Marker) (BOB1/2424) Antibody |
|||
| BNC552424-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2424), CF555 conjugate, Concentration: 0.1mg/mL |
|||
BOB.1 (B-Cell Marker) (BOB1/2424) Antibody |
|||
| BNC552424-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2424), CF555 conjugate, Concentration: 0.1mg/mL |
|||
BOB.1 (B-Cell Marker) (BOB1/2425) Antibody |
|||
| BNC552425-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2425), CF555 conjugate, Concentration: 0.1mg/mL |
|||
BOB.1 (B-Cell Marker) (BOB1/2425) Antibody |
|||
| BNC552425-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2425), CF555 conjugate, Concentration: 0.1mg/mL |
|||
BOB.1 (B-Cell Marker) (BOB1/2423) Antibody |
|||
| BNC612423-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2423), CF660R conjugate, Concentration: 0.1mg/mL |
|||
BOB.1 (B-Cell Marker) (BOB1/2423) Antibody |
|||
| BNC612423-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2423), CF660R conjugate, Concentration: 0.1mg/mL |
|||
BOB.1 (B-Cell Marker) (BOB1/2424) Antibody |
|||
| BNC612424-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2424), CF660R conjugate, Concentration: 0.1mg/mL |
|||
BOB.1 (B-Cell Marker) (BOB1/2424) Antibody |
|||
| BNC612424-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2424), CF660R conjugate, Concentration: 0.1mg/mL |
|||
BOB.1 (B-Cell Marker) (BOB1/2425) Antibody |
|||
| BNC612425-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2425), CF660R conjugate, Concentration: 0.1mg/mL |
|||
BOB.1 (B-Cell Marker) (BOB1/2425) Antibody |
|||
| BNC612425-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2425), CF660R conjugate, Concentration: 0.1mg/mL |
|||
BOB.1 (B-Cell Marker) (BOB1/2423) Antibody |
|||
| BNCP2423-250 | Biotium | 250uL | 472.8 EUR |
|
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2423), PerCP conjugate, Concentration: 0.1mg/mL |
|||
BOB.1 (B-Cell Marker) (BOB1/2424) Antibody |
|||
| BNCP2424-250 | Biotium | 250uL | 472.8 EUR |
|
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2424), PerCP conjugate, Concentration: 0.1mg/mL |
|||
BOB.1 (B-Cell Marker) (BOB1/2425) Antibody |
|||
| BNCP2425-250 | Biotium | 250uL | 472.8 EUR |
|
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2425), PerCP conjugate, Concentration: 0.1mg/mL |
|||
BOB.1 (B-Cell Marker) (BOB1/2423) Antibody |
|||
| BNCR2423-250 | Biotium | 250uL | 472.8 EUR |
|
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2423), RPE conjugate, Concentration: 0.1mg/mL |
|||
BOB.1 (B-Cell Marker) (BOB1/2424) Antibody |
|||
| BNCR2424-250 | Biotium | 250uL | 472.8 EUR |
|
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2424), RPE conjugate, Concentration: 0.1mg/mL |
|||
BOB.1 (B-Cell Marker) (BOB1/2425) Antibody |
|||
| BNCR2425-250 | Biotium | 250uL | 472.8 EUR |
|
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2425), RPE conjugate, Concentration: 0.1mg/mL |
|||
BOB.1 (B-Cell Marker) (BOB1/2423) Antibody |
|||
| BNC402423-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2423), CF640R conjugate, Concentration: 0.1mg/mL |
|||
BOB.1 (B-Cell Marker) (BOB1/2423) Antibody |
|||
| BNC402423-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2423), CF640R conjugate, Concentration: 0.1mg/mL |
|||
BOB.1 (B-Cell Marker) (BOB1/2424) Antibody |
|||
| BNC402424-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2424), CF640R conjugate, Concentration: 0.1mg/mL |
|||
BOB.1 (B-Cell Marker) (BOB1/2424) Antibody |
|||
| BNC402424-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2424), CF640R conjugate, Concentration: 0.1mg/mL |
|||
BOB.1 (B-Cell Marker) (BOB1/2425) Antibody |
|||
| BNC402425-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2425), CF640R conjugate, Concentration: 0.1mg/mL |
|||
BOB.1 (B-Cell Marker) (BOB1/2425) Antibody |
|||
| BNC402425-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2425), CF640R conjugate, Concentration: 0.1mg/mL |
|||
BOB.1 (B-Cell Marker) (BOB1/2423) Antibody |
|||
| BNC432423-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2423), CF543 conjugate, Concentration: 0.1mg/mL |
|||
BOB.1 (B-Cell Marker) (BOB1/2423) Antibody |
|||
| BNC432423-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2423), CF543 conjugate, Concentration: 0.1mg/mL |
|||
BOB.1 (B-Cell Marker) (BOB1/2424) Antibody |
|||
| BNC432424-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2424), CF543 conjugate, Concentration: 0.1mg/mL |
|||
BOB.1 (B-Cell Marker) (BOB1/2424) Antibody |
|||
| BNC432424-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2424), CF543 conjugate, Concentration: 0.1mg/mL |
|||
BOB.1 (B-Cell Marker) (BOB1/2425) Antibody |
|||
| BNC432425-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2425), CF543 conjugate, Concentration: 0.1mg/mL |
|||
BOB.1 (B-Cell Marker) (BOB1/2425) Antibody |
|||
| BNC432425-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2425), CF543 conjugate, Concentration: 0.1mg/mL |
|||
BOB.1 (B-Cell Marker) (BOB1/2423) Antibody |
|||
| BNC052423-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2423), CF405M conjugate, Concentration: 0.1mg/mL |
|||
BOB.1 (B-Cell Marker) (BOB1/2423) Antibody |
|||
| BNC052423-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2423), CF405M conjugate, Concentration: 0.1mg/mL |
|||
BOB.1 (B-Cell Marker) (BOB1/2424) Antibody |
|||
| BNC052424-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2424), CF405M conjugate, Concentration: 0.1mg/mL |
|||
BOB.1 (B-Cell Marker) (BOB1/2424) Antibody |
|||
| BNC052424-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2424), CF405M conjugate, Concentration: 0.1mg/mL |
|||
BOB.1 (B-Cell Marker) (BOB1/2425) Antibody |
|||
| BNC052425-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2425), CF405M conjugate, Concentration: 0.1mg/mL |
|||
BOB.1 (B-Cell Marker) (BOB1/2425) Antibody |
|||
| BNC052425-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2425), CF405M conjugate, Concentration: 0.1mg/mL |
|||
BOB.1 (B-Cell Marker) (BOB1/2423) Antibody |
|||
| BNC812423-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2423), CF680R conjugate, Concentration: 0.1mg/mL |
|||
BOB.1 (B-Cell Marker) (BOB1/2423) Antibody |
|||
| BNC812423-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2423), CF680R conjugate, Concentration: 0.1mg/mL |
|||
BOB.1 (B-Cell Marker) (BOB1/2424) Antibody |
|||
| BNC812424-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2424), CF680R conjugate, Concentration: 0.1mg/mL |
|||
BOB.1 (B-Cell Marker) (BOB1/2424) Antibody |
|||
| BNC812424-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2424), CF680R conjugate, Concentration: 0.1mg/mL |
|||
BOB.1 (B-Cell Marker) (BOB1/2425) Antibody |
|||
| BNC812425-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2425), CF680R conjugate, Concentration: 0.1mg/mL |
|||
BOB.1 (B-Cell Marker) (BOB1/2425) Antibody |
|||
| BNC812425-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2425), CF680R conjugate, Concentration: 0.1mg/mL |
|||
BOB.1 (B-Cell Marker) (BOB1/2423) Antibody |
|||
| BNC802423-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2423), CF680 conjugate, Concentration: 0.1mg/mL |
|||
BOB.1 (B-Cell Marker) (BOB1/2423) Antibody |
|||
| BNC802423-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2423), CF680 conjugate, Concentration: 0.1mg/mL |
|||
BOB.1 (B-Cell Marker) (BOB1/2424) Antibody |
|||
| BNC802424-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2424), CF680 conjugate, Concentration: 0.1mg/mL |
|||
BOB.1 (B-Cell Marker) (BOB1/2424) Antibody |
|||
| BNC802424-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2424), CF680 conjugate, Concentration: 0.1mg/mL |
|||
BOB.1 (B-Cell Marker) (BOB1/2425) Antibody |
|||
| BNC802425-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2425), CF680 conjugate, Concentration: 0.1mg/mL |
|||
BOB.1 (B-Cell Marker) (BOB1/2425) Antibody |
|||
| BNC802425-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2425), CF680 conjugate, Concentration: 0.1mg/mL |
|||
BOB.1 (B-Cell Marker) (BOB1/2423) Antibody |
|||
| BNCH2423-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2423), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||
BOB.1 (B-Cell Marker) (BOB1/2423) Antibody |
|||
| BNCH2423-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2423), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||
BOB.1 (B-Cell Marker) (BOB1/2424) Antibody |
|||
| BNCH2424-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2424), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||
BOB.1 (B-Cell Marker) (BOB1/2424) Antibody |
|||
| BNCH2424-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2424), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||
BOB.1 (B-Cell Marker) (BOB1/2425) Antibody |
|||
| BNCH2425-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2425), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||
BOB.1 (B-Cell Marker) (BOB1/2425) Antibody |
|||
| BNCH2425-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2425), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL |
|||
BOB.1 (B-Cell Marker) (BOB1/2423) Antibody |
|||
| BNUB2423-100 | Biotium | 100uL | 316.8 EUR |
|
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2423), Concentration: 0.2mg/mL |
|||
BOB.1 (B-Cell Marker) (BOB1/2423) Antibody |
|||
| BNUB2423-50 | Biotium | 50uL | 486 EUR |
|
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2423), 1mg/mL |
|||
BOB.1 (B-Cell Marker) (BOB1/2423) Antibody |
|||
| BNUB2423-500 | Biotium | 500uL | 615.6 EUR |
|
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2423), Concentration: 0.2mg/mL |
|||
BOB.1 (B-Cell Marker) (BOB1/2424) Antibody |
|||
| BNUB2424-100 | Biotium | 100uL | 316.8 EUR |
|
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2424), Concentration: 0.2mg/mL |
|||
BOB.1 (B-Cell Marker) (BOB1/2424) Antibody |
|||
| BNUB2424-50 | Biotium | 50uL | 486 EUR |
|
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2424), 1mg/mL |
|||
BOB.1 (B-Cell Marker) (BOB1/2424) Antibody |
|||
| BNUB2424-500 | Biotium | 500uL | 615.6 EUR |
|
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2424), Concentration: 0.2mg/mL |
|||
BOB.1 (B-Cell Marker) (BOB1/2425) Antibody |
|||
| BNUB2425-100 | Biotium | 100uL | 316.8 EUR |
|
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2425), Concentration: 0.2mg/mL |
|||
BOB.1 (B-Cell Marker) (BOB1/2425) Antibody |
|||
| BNUB2425-50 | Biotium | 50uL | 486 EUR |
|
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2425), 1mg/mL |
|||
BOB.1 (B-Cell Marker) (BOB1/2425) Antibody |
|||
| BNUB2425-500 | Biotium | 500uL | 615.6 EUR |
|
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2425), Concentration: 0.2mg/mL |
|||
BOB.1 (B-Cell Marker) (BOB1/2423) Antibody |
|||
| BNC042423-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2423), CF405S conjugate, Concentration: 0.1mg/mL |
|||
BOB.1 (B-Cell Marker) (BOB1/2423) Antibody |
|||
| BNC042423-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2423), CF405S conjugate, Concentration: 0.1mg/mL |
|||
BOB.1 (B-Cell Marker) (BOB1/2424) Antibody |
|||
| BNC042424-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2424), CF405S conjugate, Concentration: 0.1mg/mL |
|||
BOB.1 (B-Cell Marker) (BOB1/2424) Antibody |
|||
| BNC042424-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2424), CF405S conjugate, Concentration: 0.1mg/mL |
|||
BOB.1 (B-Cell Marker) (BOB1/2425) Antibody |
|||
| BNC042425-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2425), CF405S conjugate, Concentration: 0.1mg/mL |
|||
BOB.1 (B-Cell Marker) (BOB1/2425) Antibody |
|||
| BNC042425-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2425), CF405S conjugate, Concentration: 0.1mg/mL |
|||
BOB.1 (B-Cell Marker) (BOB1/2423) Antibody |
|||
| BNC682423-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2423), CF568 conjugate, Concentration: 0.1mg/mL |
|||
BOB.1 (B-Cell Marker) (BOB1/2423) Antibody |
|||
| BNC682423-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2423), CF568 conjugate, Concentration: 0.1mg/mL |
|||
BOB.1 (B-Cell Marker) (BOB1/2424) Antibody |
|||
| BNC682424-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2424), CF568 conjugate, Concentration: 0.1mg/mL |
|||
BOB.1 (B-Cell Marker) (BOB1/2424) Antibody |
|||
| BNC682424-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2424), CF568 conjugate, Concentration: 0.1mg/mL |
|||
BOB.1 (B-Cell Marker) (BOB1/2425) Antibody |
|||
| BNC682425-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2425), CF568 conjugate, Concentration: 0.1mg/mL |
|||
BOB.1 (B-Cell Marker) (BOB1/2425) Antibody |
|||
| BNC682425-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2425), CF568 conjugate, Concentration: 0.1mg/mL |
|||
BOB.1 (B-Cell Marker) (BOB1/2423) Antibody |
|||
| BNC702423-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2423), CF770 conjugate, Concentration: 0.1mg/mL |
|||
BOB.1 (B-Cell Marker) (BOB1/2423) Antibody |
|||
| BNC702423-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2423), CF770 conjugate, Concentration: 0.1mg/mL |
|||
BOB.1 (B-Cell Marker) (BOB1/2424) Antibody |
|||
| BNC702424-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2424), CF770 conjugate, Concentration: 0.1mg/mL |
|||
BOB.1 (B-Cell Marker) (BOB1/2424) Antibody |
|||
| BNC702424-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2424), CF770 conjugate, Concentration: 0.1mg/mL |
|||
BOB.1 (B-Cell Marker) (BOB1/2425) Antibody |
|||
| BNC702425-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2425), CF770 conjugate, Concentration: 0.1mg/mL |
|||
BOB.1 (B-Cell Marker) (BOB1/2425) Antibody |
|||
| BNC702425-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2425), CF770 conjugate, Concentration: 0.1mg/mL |
|||
BOB.1 (B-Cell Marker) (BOB1/2423) Antibody |
|||
| BNCAP2423-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2423), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
BOB.1 (B-Cell Marker) (BOB1/2423) Antibody |
|||
| BNCAP2423-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2423), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
BOB.1 (B-Cell Marker) (BOB1/2424) Antibody |
|||
| BNCAP2424-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2424), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
BOB.1 (B-Cell Marker) (BOB1/2424) Antibody |
|||
| BNCAP2424-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2424), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
BOB.1 (B-Cell Marker) (BOB1/2425) Antibody |
|||
| BNCAP2425-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2425), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
BOB.1 (B-Cell Marker) (BOB1/2425) Antibody |
|||
| BNCAP2425-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2425), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL |
|||
BOB.1 (B-Cell Marker) (BOB1/2423) Antibody |
|||
| BNC882423-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2423), CF488A conjugate, Concentration: 0.1mg/mL |
|||
BOB.1 (B-Cell Marker) (BOB1/2423) Antibody |
|||
| BNC882423-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2423), CF488A conjugate, Concentration: 0.1mg/mL |
|||
BOB.1 (B-Cell Marker) (BOB1/2424) Antibody |
|||
| BNC882424-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2424), CF488A conjugate, Concentration: 0.1mg/mL |
|||
BOB.1 (B-Cell Marker) (BOB1/2424) Antibody |
|||
| BNC882424-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2424), CF488A conjugate, Concentration: 0.1mg/mL |
|||
BOB.1 (B-Cell Marker) (BOB1/2425) Antibody |
|||
| BNC882425-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2425), CF488A conjugate, Concentration: 0.1mg/mL |
|||
BOB.1 (B-Cell Marker) (BOB1/2425) Antibody |
|||
| BNC882425-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2425), CF488A conjugate, Concentration: 0.1mg/mL |
|||
BOB.1 (B-Cell Marker) (BOB1/2423) Antibody |
|||
| BNC472423-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2423), CF647 conjugate, Concentration: 0.1mg/mL |
|||
BOB.1 (B-Cell Marker) (BOB1/2423) Antibody |
|||
| BNC472423-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2423), CF647 conjugate, Concentration: 0.1mg/mL |
|||
BOB.1 (B-Cell Marker) (BOB1/2424) Antibody |
|||
| BNC472424-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2424), CF647 conjugate, Concentration: 0.1mg/mL |
|||
BOB.1 (B-Cell Marker) (BOB1/2424) Antibody |
|||
| BNC472424-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2424), CF647 conjugate, Concentration: 0.1mg/mL |
|||
BOB.1 (B-Cell Marker) (BOB1/2425) Antibody |
|||
| BNC472425-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2425), CF647 conjugate, Concentration: 0.1mg/mL |
|||
BOB.1 (B-Cell Marker) (BOB1/2425) Antibody |
|||
| BNC472425-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2425), CF647 conjugate, Concentration: 0.1mg/mL |
|||
BOB.1 (B-Cell Marker) (BOB1/2423) Antibody |
|||
| BNCB2423-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2423), Biotin conjugate, Concentration: 0.1mg/mL |
|||
BOB.1 (B-Cell Marker) (BOB1/2423) Antibody |
|||
| BNCB2423-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2423), Biotin conjugate, Concentration: 0.1mg/mL |
|||
BOB.1 (B-Cell Marker) (BOB1/2424) Antibody |
|||
| BNCB2424-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2424), Biotin conjugate, Concentration: 0.1mg/mL |
|||
BOB.1 (B-Cell Marker) (BOB1/2424) Antibody |
|||
| BNCB2424-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2424), Biotin conjugate, Concentration: 0.1mg/mL |
|||
BOB.1 (B-Cell Marker) (BOB1/2425) Antibody |
|||
| BNCB2425-100 | Biotium | 100uL | 279.6 EUR |
|
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2425), Biotin conjugate, Concentration: 0.1mg/mL |
|||
BOB.1 (B-Cell Marker) (BOB1/2425) Antibody |
|||
| BNCB2425-500 | Biotium | 500uL | 654 EUR |
|
Description: Primary antibody against BOB.1 (B-Cell Marker) (BOB1/2425), Biotin conjugate, Concentration: 0.1mg/mL |
|||
 Rabbit Polyclonal Antibody to Human Topoisomerase IIα |
|||
| TG2011-1 | TopoGen | 250 units | 496.8 EUR |
 Polyclonal Rabbit anti-sEH |
|||
| SEH-1 | Detroit R&D | 50 uL | 336 EUR |
 Anti-Sumo 1 Rabbit Monoclonal Antibody |
|||
| M00631-1 | BosterBio | 100ug/vial | 476.4 EUR |
|
Description: Rabbit Monoclonal Sumo 1 Antibody. Validated in IP, IF, IHC, WB and tested in Human, Mouse, Rat. |
|||
 Anti-Cytokeratin 1 Rabbit Monoclonal Antibody |
|||
| M01639-1 | BosterBio | 100ug/vial | 476.4 EUR |
|
Description: Rabbit Monoclonal Cytokeratin 1 Antibody. Validated in WB and tested in Human, Mouse, Rat. |
|||
 Anti-Integrin beta 1 Rabbit Monoclonal Antibody |
|||
| M00772-1 | BosterBio | 100ug/vial | 476.4 EUR |
|
Description: Rabbit Monoclonal Integrin beta 1 Antibody. Validated in IHC, WB and tested in Human, Mouse, Rat. |
|||
 Anti-ARG1/Arginase 1 Rabbit Monoclonal Antibody |
|||
| M01106-1 | BosterBio | 100ug/vial | 476.4 EUR |
|
Description: Rabbit Monoclonal ARG1/Arginase 1 Antibody. Validated in IP, WB and tested in Human, Mouse, Rat. |
|||
 Anti-MLANA/Mart 1 Rabbit Monoclonal Antibody |
|||
| M02033-1 | BosterBio | 100ug/vial | 476.4 EUR |
|
Description: Rabbit Monoclonal MLANA/Mart 1 Antibody. Validated in IF, WB and tested in Human. |
|||
 Anti-DSG1/Desmoglein 1 Rabbit Monoclonal Antibody |
|||
| M02655-1 | BosterBio | 100ug/vial | 476.4 EUR |
|
Description: Rabbit Monoclonal DSG1/Desmoglein 1 Antibody. Validated in IF, IHC, ICC, WB and tested in Human, Mouse, Rat. |
|||
 Anti-HMGB1/Hmg 1 Rabbit Monoclonal Antibody |
|||
| M00066-1 | BosterBio | 100ug/vial | 476.4 EUR |
|
Description: Rabbit Monoclonal HMGB1/Hmg 1 Antibody. Validated in Flow Cytometry, IF, IHC, ICC, WB and tested in Human, Mouse, Rat. |
|||
 Anti-p27 KIP 1 Rabbit Monoclonal Antibody |
|||
| M00173-1 | BosterBio | 100ug/vial | 476.4 EUR |
|
Description: Anti-p27 KIP 1 Rabbit Monoclonal Antibody tested for Flow Cytometry, IP, IF, IHC, ICC, WB in Human, Rat |
|||
 Anti-MHC class 1 Rabbit Monoclonal Antibody |
|||
| M00194-1 | BosterBio | 100ug/vial | 476.4 EUR |
|
Description: Rabbit Monoclonal MHC class 1 Antibody. Validated in IP, IF, IHC, WB and tested in Human. |
|||
 Histone H3K4 Methylation Antibody Panel Pack |
|||
| C10005 | EpiGentek |
|
|
 Histone H3K9 Methylation Antibody Panel Pack |
|||
| C10006 | EpiGentek |
|
|
 Histone H3K27 Methylation Antibody Panel Pack |
|||
| C10007 | EpiGentek |
|
|
 Histone H3K36 Methylation Antibody Panel Pack |
|||
| C10008 | EpiGentek |
|
|
 Histone H3K79 Methylation Antibody Panel Pack |
|||
| C10009 | EpiGentek |
|
|
 Histone H4K20 Methylation Antibody Panel Pack |
|||
| C10012 | EpiGentek |
|
|
 Histone H4 Acetylation Antibody Panel Pack |
|||
| C10013 | EpiGentek |
|
|
 Histone H3 Phosphorylation Antibody Panel Pack |
|||
| C10014 | EpiGentek |
|
|
 Histone H3R2 Methylation Antibody Panel Pack |
|||
| C10015 | EpiGentek |
|
|
 Histone H3R8 Methylation Antibody Panel Pack |
|||
| C10016 | EpiGentek |
|
|
 Histone H3R17 Methylation Antibody Panel Pack |
|||
| C10017 | EpiGentek |
|
|
 Histone H3R26 Methylation Antibody Panel Pack |
|||
| C10018 | EpiGentek |
|
|
 Histone H4R3 Methylation Antibody Panel Pack |
|||
| C10019 | EpiGentek |
|
|
 HRP-Goat Anti-Mouse Secondary Antibody |
|||
| A12003 | EpiGentek |
|
|
 DNA Methylation Antibody Panel Pack I |
|||
| C20000 | EpiGentek |
|
|
 Histone H3 Acetylation Antibody Panel Pack I |
|||
| C10010 | EpiGentek |
|
|
 Histone H3 Acetylation Antibody Panel Pack II |
|||
| C10011 | EpiGentek |
|
|
 Goat Anti-Rat Secondary Antibody, Biotin Conjugated |
|||
| A12002 | EpiGentek |
|
|
 Histone H3 Methylation Antibody Panel Pack I – Active Genes |
|||
| C10000 | EpiGentek |
|
|
 Histone H3 Methylation Antibody Panel Pack I – Repression Genes |
|||
| C10001 | EpiGentek |
|
|
Bob 1 Rabbit Polyclonal Antibody